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Background: Alix participates in fundamental cellular processes, but how it is regulated remains unknown.
Results: Alix is ubiquitinated by the Ozz-E3 ligase and participates in actin cytoskeleton remodeling, filopodia formation, and
myoblast migration.
Conclusion:Ozz influences Alix conformation and in turn the extent of ubiquitination in Alix.
Significance:Ozz-E3 ligase regulates Alix concentration at sites where the actin cytoskeleton undergoes remodeling.
Alix/AIP1 is a multifunctional adaptor protein that partici-
pates in basic cellular processes, including membrane traffick-
ing and actin cytoskeleton assembly, by binding selectively to a
variety of partner proteins. However, the mechanisms regulat-
ingAlix turnover, subcellular distribution, and function inmus-
cle cells are unknown. We now report that Alix is expressed in
skeletal muscle throughout myogenic differentiation. In myo-
tubes, a specific pool of Alix colocalizes with Ozz, the substrate-
binding component of themuscle-specific ubiquitin ligase com-
plex Ozz-E3. We found that interaction of the two endogenous
proteins in the differentiatedmuscle fibers changesAlix confor-
mation and promotes its ubiquitination. This in turn regulates
the levels of the protein in specific subcompartments, in partic-
ular the one containing the actin polymerization factor cortac-
tin. In Ozz/ myotubes, the levels of filamentous (F)-actin is
perturbed, and Alix accumulates in large puncta positive for
cortactin. In line with this observation, we show that the knock-
down of Alix expression in C2C12 muscle cells affects the
amount and distribution of F-actin, which consequently leads to
changes in cellmorphology, impaired formationof sarcolemmal
protrusions, and defective cell motility. These findings suggest
that the Ozz-E3 ligase regulates Alix at sites where the actin
cytoskeleton undergoes remodeling.
During the early stages of vertebrate limb development, skel-
etal muscle progenitor cells migrate from the lateral lip of the
dermomyotome into the limb buds, where they differentiate
and fuse to form the primary myotubes of limb muscles (1).
Similarly, in response to muscle lesions or disease, migration
of satellite cells is required to lead the regeneration of the adult
skeletal muscle. To migrate, individual cells must correctly
sense or respond to migratory cues and translate a number of
different inputs into appropriate cellular responses. First, a cell
must discern the direction in which to move and must orient
itself (i.e. polarize) so to effect directed migration. This process
is largely coordinated by membrane receptors, which interpret
local migratory cues and transfer them to the underlying cyto-
skeleton (2). Lamellipodia and filopodia are then extended from
the leading edge of the cell in the direction of migration. New
adhesions to the extracellular matrix are initiated at the leading
edge, and these serve to pull the cell forward (3). Central to this
process is, on one hand, the actomyosin contractile machinery
and the microtubules (4, 5), and on the other hand the forma-
tion ofmembrane protrusions (6, 7). The latter process requires
actin polymerization followed by the stabilization of the actin
filaments in the area of membrane extensions (6, 7). Although
the mechanisms regulating cell migration remain poorly
understood, this cellular process has been linked to various
components of the endocytosis and the actin-polymerization
machinery (8, 9).
Alix/AIP1 (ALG-2 interacting proteinXor 1) is an evolution-
ary conserved adaptor protein that was first identified as an
interactor of ALG-2 (apoptosis-linked gene 2), and in this
capacity it was found to cooperate with ALG-2 in promoting
apoptosis (10, 11). More recent reports have implicated Alix in
other basic cellular processes, which all hinge on membrane
trafficking, endosomal sorting, and remodeling of the actin
cytoskeleton (12–14). These multitasking properties of Alix
derive from the ability of the protein to interact with a plethora
of partner proteins, which are themselves components of large
oligomeric complexes. By interacting with the endosomal sort-
ing complexes required for transport, ESCRT I and III, Alix
synergistically coordinates endocytosis and recycling of mem-
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brane receptors, viral budding, and cytokinesis (13–20). Rele-
vant to this study are the findings that Alix also participates in
cytoskeleton remodeling by binding with F-actin, -actinin,
cortactin, and focal adhesion kinase (14, 21). These multiple
and seemingly diverse interactions of Alix are made possible by
the primary structure of the protein that includes at least three
distinct protein-protein interaction domains as follows: the
N-terminal Bro1 domain; a middle region called the V-domain
and containing a coiled-coil motif; and a C-terminal proline-
rich region (PRR),5 which is a potential docking site for proteins
containing Src homology 3 domains (22–24). Both theBro1 and
the PRR domains of Alix bind F-actin, whereas the N-terminal
half of its V-domain interacts with -actinin and cortactin.
Given that Alix directly interacts with -actinin and promotes
its association with F-actin in fibroblast, a direct role of Alix in
the F-actin bundling step of stress fiber assembly has been pro-
posed (21).
It is noteworthy that among the proteins known to inter-
act directly or indirectly with Alix are components of the
ubiquitin pathway, including the deubiquitinating enzyme
Doa4 and the E3 ubiquitin ligases Cbl, POSH (plenty of Src
homology 3), and Nedd4-1 (25–28). The latter two ligases
have been shown to ubiquitinate and cooperate with Alix
during the process of HIV-1 release. However, the functional
significance of Alix ubiquitination by these ligases is still
poorly understood.
Despite the wealth of information on the proteins that inter-
act with Alix and the physiological processes to which they
contribute, the mechanisms regulating the turnover and sub-
cellular distribution of Alix are still largely unknown. We now
report that in muscle cells Alix is a substrate of the RING-type
ubiquitin ligase,Ozz-E3.Ozz (also known asNeurl2 orNeutral-
ized-like protein 2) is a member of the SOCS (suppressor of
cytokine signaling) family of proteins and is the substrate-rec-
ognition module of Ozz-E3 (29). This ligase complex includes,
beside Ozz, Elongin B/C (Elo B/C), Rbx1, and Cullin 5 (Cul5)
(29).Wehave shownpreviously thatOzz-E3 plays an active role
inmyofiber differentiation andmaturation, during embryogen-
esis and muscle regeneration, by targeting and ubiquitinating
two proteins within macromolecular complexes as follows: the
sarcolemma-associated pool of -catenin, and the sarcomeric
embryonic myosin heavy chain (MyHCemb) (29, 30). Ozz/
mice develop overt sarcomeric defects, which we attribute in
part to impaired turnover of cadherin-associated-catenin and
to incomplete exchange of embryonic MyHC isoforms with
their neonatal and adult counterparts within the sarcomere,
duringmyofiber differentiation (29, 30). These findings point to
distinct functions ofOzz tomaintain the integrity of at least two
cell compartments, containing actin filaments, the sarcolem-
mal-associated cortical cytoskeleton and the sarcomere. Here,
we demonstrate that Alix modulates actin and membrane
dynamics in muscle cells and propose that Ozz intervention in
this process in required at specific subcellular sites of the dif-
ferentiated myotubes.
EXPERIMENTAL PROCEDURES
Ethics Statement—The animal work was first approved by
the Animal Care and Use Committee at St. Jude Children’s
Research Hospital that governs animal research at this Institu-
tion (approval ID 388). The research was then conducted in
compliance with appropriate guidelines from the Institutional
Animal Care and Use Committee, the Association for Assess-
ment and Accreditation of Laboratory Animal Care Interna-
tional, the United States Public Health Service, and United
States Department of Agriculture animal welfare regulations.
All surgery was performed under sodium pentobarbital anes-
thesia, and all efforts were made to minimize suffering.
Antibodies andReagents—Rabbit anti-Ozz antibodywas pre-
pared as described (29). The antibody was diluted 1:500 for
immunoblotting and 1:10 for immunofluorescence. Polyclonal
antibodies against Alix were generated by Rockland Immuno-
chemicals Inc. (Gilbertsville, PA). Alexa Fluor 555-conjugated
polyclonal anti-Alix was labeled and purified according to the
manufacturer’s procedure. Commercial antibodies included
the following: mouse anti-AIP1/Alix for immunoblotting (BD
Transduction Laboratories); anti-Alix (clones 1A12, 3A9, and
2H12, Santa Cruz Biotechnology) for immunofluorescence;
anti-GAPDH (Millipore); anti-pan-actin (Cell Signaling); anti-
-enolase (Santa Cruz Biotechnology); anti--catenin (BD
Transduction Laboratories); anti-polyubiquitin (Thermo Sci-
entific); anti-cortactin (Millipore); anti-FLAG (Sigma); normal
rabbit IgG (Santa Cruz Biotechnology); Cy3-conjugated
anti-mouse IgG and Cy3-conjugated anti-rabbit (Jackson
ImmunoResearch); Alexa Fluor 488-conjugated anti-mouse
1:500 (Invitrogen); and FITC-phalloidin (Sigma). Synthetic
siGENOME, ON-TARGETplus SMARTpool siRNAs targeting
Alix, standard negative controls (siCONTROL NonTarget-
ing siRNAs andON-TARGETplus siCONTROLNonTargeting
Pool), and the transfection reagent DharmaFECT3 were pur-
chased from Dharmacon. Ozz was transiently expressed in
C2C12 using the MSCV-based bicistronic retroviral vector
encoding full-length Ozz and the green fluorescent protein
(MSCV-Ozz-IRES-GFP) (31).
Yeast Two-hybrid Screening—Screening of an E14.5 mouse
cDNA library (gift of Dr. P. McKinnon, Dept. of Genetics, St.
Jude Children’s Research Hospital) for putative Ozz-binding
partners was performed as described previously (29, 30). Three
cDNAclones encodingAlixwere isolated, the smallest of which
encoded a fragment from 424 to 868 amino acids. To map the
minimal regionmediating the interaction with Ozz, three dele-
tion mutants of this shorter Alix fragment were generated by
PCR using Pfu DNA polymerase (Stratagene) and appropriate
primers (see below). These PCR fragments were digested with
SalI and NotI and subcloned into the prey vector pEXP-AD502
in-frame with theGAL4 activation domain. The full-length (bp
1–845)Ozzwas subcloned in-framewith theGAL4DNAbind-
ing domain of the bait vector pDBLeu. All resulting constructs
were confirmed by sequence analysis. The bait and prey con-
structs were co-transformed into yeast strain Mav203. Two
reporter genes (lacZ and HIS3) were employed to examine the
interaction (Invitrogen). For the construction of the deletion
mutants of Alix to be tested in the yeast two-hybrid assay, the
5 Theabbreviationsusedare: PRR, proline-rich region;MSCV,murine stemcell
virus.
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following primers were used: M-533–868, forward AAAAAG-
TCGACCGCCATCCCCTCTGCTAACCC and reverse TAA-
TTGCGGCCGCCTACTGCTGTGGATAGTAAGACTGC-
TGC; M-667–868, forward AAATTGTCGACCGTAGCT-
AACTTGAAGGAGGGC and reverse TAATTGCGGCCGC-
CTACTGCTGTGGATAGTAAGACTGCTGC; M-771–868,
forward AAATTGTCGACCGCTTCTGCTGCTGCTGCCC-
CTGC and reverse TAATTGCGGCCGCCTACTGCT-
GTGGATAGTAAGACTGCTGC.
Cell Culture Methods—The mouse myoblast cell line C2C12
was maintained in high glucose DMEM supplemented with
20% fetal calf serum (FCS), sodium pyruvate, L-glutamine, pen-
icillin, and streptomycin (proliferation medium) at 37 °C in a
humidified atmosphere with 5% CO2. Myotube differentiation
was induced when the medium was supplemented with 2%
horse serum in place of FCS (differentiation medium). Plasmid
and siRNAs were transfected using DharmaFECT3 (Dharma-
con) according to the manufacturer’s instructions. Briefly,
C2C12 cells were plated 1 day before transfection in 10-cm
dishes (2 105 cells/dish). On the day of the transfection, the
cells were50% confluent. 250 l of siRNA duplex (2 M) was
diluted in 250 l of DMEM (without FCS, sodium pyruvate,
L-glutamine, penicillin, and streptomycin) and mixed with 20
l of DharmaFECT3 (Dharmacon). The mixture was added to
cells grown in DMEM (without FCS, penicillin, and streptomy-
cin). After 2–3h, FCSwas added to a final concentration of 20%.
The cells were incubated for 48 h in the presence of the siRNA
oligonucleotides. Then cells from each dish were re-plated into
two new dishes and incubated for another 24 h in proliferation
medium (for D0) or 72 h in differentiation medium (for D3), in
the absence of siRNA. For the three-dimensional cultures,
C2C12 cells were seeded inside a 50-mm thick collagen I gel
(diluted 1:10; BD Biosciences), in inserts for 24-well plates
(50,000 cells/insert; BD Biosciences). The three-dimensional
culture was then submerged in proliferating or differentiating
mediumand incubated for 24 or 72 h.Cellswere fixedwith 2.5%
glutaraldehyde in sodium cacodylate buffer and processed for
electron microscopy (32). Primary myoblast cultures were
established as described previously (29).
F-actin FACS Assay—For FACS assay, mock-treated and
Alix-silenced C2C12 cells were trypsinized, and 106 cells were
fixed in 4% paraformaldehyde/PBS before permeabilization
with 0.03% Triton X-100 and stained with 33 nM FITC-phalloi-
din.Mean cellular F-actin content, as determined by phalloidin
staining, was quantified using the FACScan (BD Biosciences).
In Vitro Wound Healing and Cell Attachment Assays—For
wound healing assay, siRNA- and mock-treated C2C12 cells
were replated, and after 24 h of incubation, cells were scratched
with amicropipette tip. The culturemediumwas replaced with
completed DMEM, and after culture for 24 h, cell migration
was observed with a Leica inverted microscope. To analyze the
process of adhesion, the rate of attachment to plastic of siRNA-
versus mock-treated C2C12 cells was tested using the in vitro
cell attachment assays. Trypsinized cells were washed once and
resuspended in prewarmed DMEM containing 20% FBS at a
density of 104 cells/cm2. Single cell suspensions were added to
6-well dishes. At different times (6, 10, 20, 40, and 60 min), the
wells were gently washed three times under constant agitation
with phosphate-buffered saline (PBS) to remove nonadherent
cells; the adherent cells were then trypsinized and counted.
Results were expressed as percent of attachment as compared
with initial seeded cells that represented 100% of attachment.
Transmission Electron Microscopy—Cells were cultured on
24-well plate inserts (BD Biosciences) and were treated as
described previously (33).
Subcellular Fractionation and Analysis of in Vivo Alix
Ubiquitination—Cytoplasmic,membrane/organelle, nuclear, and
cytoskeletal fractions were prepared using a ProteoExtract
subcellular proteome extraction kit (Calbiochem, Merck)
according to the manufacturer’s instructions. Protein concen-
trationswere determined atA595, usingBSAas standard. 20–30
g of cytoplasmic protein or cell equivalent amounts of the
other fractions were electrophoresed (100 V, 60 min) on SDS-
polyacrylamide gels, and wet-blotted overnight at 90 mA.
Membranes were probed with specific antibodies, followed by
HRP-conjugated goat anti-rabbit or anti-mouse IgG (Amer-
sham Biosciences). The specific secondary antibody binding
was detected with a SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific). Each of the immunoblots
included in the figures was representative of results obtained in
at least three independent experiments. To test the in vivoubiq-
uitination of Alix, 0.5–1 mg of cytosolic or membrane proteins
were adjusted to 2 mM CaCl2 (final concentrations) in a final
volume of 1 ml, pre-cleared by 1 h of incubation at room tem-
perature with 25 l of protein A/G Plus-agarose beads (Santa
Cruz Biotechnology), and then spun at 1000  g. 2 g of the
indicated antibodies or equal amounts of control IgG were
added to the supernatant, incubated overnight at 4 °C, and fol-
lowed by immunoprecipitation for 2 h of incubation at room
temperature with protein A/G Plus-agarose beads (Santa Cruz
Biotechnology). The beads were washed five times with Hypo-
tonic buffer supplemented with 0.1% Nonidet P-40, and the
bound proteins detached and run on SDS-polyacrylamide gels
under denaturing conditions. Membranes were blocked and
probed with specific antibodies and then washed before incu-
bation with species-appropriate secondary antibodies for 1 h at
room temperature.Where indicated, blots were analyzed using
an Odyssey Infrared Imaging System (LI-COR), and relevant
signal intensity was determined using LI-COR imaging soft-
ware. Each of the immunoblots included in the figures was rep-
resentative of results obtained in at least three independent
experiments.
Alix/Ozz Coimmunoprecipitation—The Ozz-Alix complex
was detected in post-nuclear fractions ofmuscle cells by immu-
noprecipitation with either the anti-Ozz or the anti-Alix anti-
bodies. Cultured C2C12 or primary myoblasts (D0) and myo-
tubes (D3) were lysed with Hypotonic buffer, incubated at 4 °C
for 30 min, and then disrupted by Dounce homogenization (40
strokes). Cellular debris and nuclei were removed by 10 min of
centrifugation at 800  g, and 0.5–1 mg of post-nuclear pro-
teins were adjusted to 2 mM CaCl2 (final concentrations) in a
final volume of 1–1.3ml and pre-cleared by 1 h of incubation at
room temperature with 25 l of protein A/G Plus-agarose
beads (Santa Cruz Biotechnology) and then spun at 1000  g.
Anti-Alix (Santa Cruz Biotechnology) or polyclonal anti-Ozz
antibodies or the appropriate antibodies used as negative con-
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trols were added to the supernatant and incubated overnight at
4 °C, followed by immunoprecipitation with protein A/G Plus-
agarose beads for 2 h of incubation at room temperature. The
beads were washed five times with Hypotonic buffer supple-
mented with 0.3% Nonidet P-40, and the bound proteins were
detached by boiling the beads in the presence of sample buffer.
50 g of the post-nuclear fraction and the whole immunopre-
cipitates were run on SDS-polyacrylamide gels under denatur-
ing conditions.
In Vitro Ubiquitination of Alix—In vitro ubiquitination was
performed as described previously (29, 30). Briefly, the entire
Ozz-E3 complex was reconstituted in vitro by coinfecting Tni-
Pro insect cells with baculoviruses encoding His-tagged Ozz/
Elongin B/Elongin C orHis-tagged Rbx1/Cullin5. The two sub-
complexes were then purified by consecutive nickel-agarose
chromatography, ion exchange chromatography, and size-ex-
clusion chromatography. 1.0 g of the purified Ozz-E3 ubiqui-
tin ligase, 150 ng of purified recombinant E1 (Calbiochem,
Merck Biosciences), 200 ng of UbcH5b (a gift of Dr. B. Schul-
man, Dept. of Structural Biology, St. Jude Children’s Research
Hospital), and 7.5 g of ubiquitin (Calbiochem, Merck) were
incubated with 1 g of a bacterially expressed GST-Alix in a
final volume of 30 l of ubiquitination buffer. Incubation was
performed at 30 °C for 1 h in the presence of 1.5 mM ATP (GE
Healthcare). To analyze the ubiquitinated products, the ubiq-
itination reaction mixtures were diluted in 500 l of RIPA
buffer, immunoprecipitated with anti-Alix (Santa Cruz Bio-
technology), resolved on a 7.5% SDS gels, and immunoblotted
with anti-ubiquitin.
Immunofluorescence and Imaging—Muscle cells were fixed
in 3% paraformaldehyde, permeabilized with 0.1% saponin in
1 PBS, and immunostained with the indicated primary anti-
bodies. Cy3 anti-rabbit IgG (The Jackson Laboratory) and
Alexa Fluor 488 anti-mouse IgG (Invitrogen) were used as sec-
ondary antibodies. Actin was detected by staining with FITC-
phalloidin (1 mM) for 40 min.
Images were acquired on a Nikon C1si confocal microscope,
with a Plan Apo 40, NA 1.3 and/or Plan Apo 60, NA 1.45
objective (Melville, NY). Computational analyses of confocal
images were performed with the NES-Elements AR 3.1 (Mel-
ville, NY), as described previously (30).
Statistical Analysis—Data were expressed as mean  S.D.
and were evaluated using Student’s t test. Mean differences
were considered statistically significant when p values were less
than 0.005 (***) or 0.05 (*).
RESULTS
Ozz Interacts with Alix in Skeletal Muscle Cells—By yeast
two-hybrid screening of an E14.5 mouse cDNA library, we
identifiedAlix as a putativeOzz-interacting partner. Either full-
length Ozz or the N-terminal half of the protein (residues
1–229), including the neutralized homologous region 1 (NHR1)
domain (residues 14–104) andmost of the NHR2 domain (res-
idues 208–242), was used as bait. Both screens yielded three
different clones with 93–96% homology to Alix that shared a
region starting at amino acid 425 until the C terminus (Fig. 1A).
The shortest clone encoded a fragment that encompassed part
of theVdomain and thePRR (fromamino acid 424 until the end
of the Alix protein). To map the minimal region mediating the
interaction with Ozz, deletion mutants of Alix were generated
and tested in a yeast two-hybrid assay, using two different
growth selections. Besides full-length Alix, three of the four
deletion mutants, M(424–868), M(533–868), and M(677–
FIGURE 1. Endogenous Ozz and Alix interact in muscle cells. A, yeast two-
hybrid screening of an E14.5 mouse cDNA library identified three clones
encoding Alix (Y2H clones) that shared a region starting at amino acid 425
until the C terminus. Highlighted are the eight putative ubiquitination sites
predictedwithmedium (blue) andhigh (red) confidence;asterisk indicates the
most conserved Lys-574 residue. The indicated Alix fragment was used in a
yeast two-hybrid assay, using two different reporter genes (HIS3 and lacZ).
The minimal Ozz-interacting region of Alix includes amino acids 677–771.
B, expression of Alix in adult tissues (QC, quadriceps; GA, gastrocnemius; TA,
tibialis anterior; SO, soleus; HT, heart; Ki, kidney; Li, liver; Lu, lung; Dia, dia-
phragm) and embryos at different embryonic stages (E14.5, E16.5, and E18.5).
C, post-nuclear fractions of proliferating (D0) and differentiated (D3) C2C12
were immunoprecipitated (IP) with anti-Ozz and with anti-SOCS3, used as
negative control. Immunoblotting with anti-Alix showed that endogenous
Alix and Ozz interact in differentiated C2C12. D, post-nuclear fractions of dif-
ferentiated primary myotubes (D3) were immunoprecipitated with anti-Alix,
or with an isotypematching control antibody (anti-FLAG), used as a negative
control. Immunoblotting with anti-Ozz showed a pattern of Ozz and Alix
interaction identical to C2C12.
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868), retained sustained interactionwithOzz. The lack of inter-
action between Ozz and the Alix fragment M(771–868)
allowed us to conclude that a minimal interacting region
between amino acids 677 and 771 ofAlix is sufficient tomediate
interaction with Ozz. This Alix region contains part of the
V-domain arm2(677–702), the full V-PRR hinge region (703–
716), and the N terminus of the PRR (717–771).
To gain insights into the significance of Ozz-Alix interaction
in vivo, we first assessed the expression pattern of Alix in dif-
ferent muscle lysates, compared with other mouse tissues, and
in embryos (Fig. 1B).We found that a predominantAlix band of
100 kDa was present in the adult skeletal muscles as well as in
the diaphragm and heart muscle. In the latter tissues and in the
systemic organs an additional band of lower molecular weight
was also detected. The ratio between these two bands varied in
different tissue samples with kidney containing only the small-
est protein (Fig. 1B, left panels). In embryos, the 100-kDa Alix
form was expressed at high levels during the early stages of
development (E14.5), and its expression decreased slightly later
in embryogenesis (Fig. 1B).
To verify the interaction between endogenous Alix and Ozz,
post-nuclear fractions of proliferating (D0) and differentiated
(D3)C2C12muscle cells were immunoprecipitatedwith a poly-
clonal anti-Ozz antibody (Fig. 1C). Immunoblotting of the
immunoprecipitates with anti-Alix antibody confirmed the
interaction between the two proteins in differentiated C2C12
(Fig. 1C); no such interaction was seen with anti-SOCS3, used
as a negative control. Similar results were obtained in post-
nuclear fractions from primary myotubes immunoprecipitated
with anti-Alix and probed on immunoblots with anti-Ozz (Fig.
1D). In this case the isotype-matching antibody anti-FLAG
(IgG1)was used as negative control. Coimmunoprecipitation of
the two proteins was more efficiently driven by anti-Alix than
anti-Ozz antibodies. This might depend on differences in the
affinity of the two antibodies to their native proteins or on the
stoichiometry of the Alix-Ozz complex in the post-nuclear
fraction. We then tested the cellular localization of the two
endogenous proteins by indirect immunofluorescent labeling
of primarymyoblasts (D0) andmyotubes (D3), followed by con-
focal microscopy and computational analyses of the two fluo-
rescent signals (Fig. 2). In line with its pattern of expression
during myogenesis (29), Ozz was undetectable by immuno-
fluorescence in the proliferating (D0) primary myoblasts,
although Alix was expressed in good amounts in the same cells
(Fig. 2A, upper panels). In contrast, Alix and Ozz colocalized in
discrete puncta throughout the cytosol of myotubes at D3 of
differentiation (Fig. 2A, lower panel, merged image). Both the
Pearson’s correlation coefficient and the cytofluorograms con-
firmed a strong colocalization of the Alix and Ozz in D3 fibers
(Fig. 2B, left and right panels, respectively); a similar analysis
performed on the Ozz null D3 myotubes served as negative
control. Together these results indicate that Alix is a bona fide
interacting partner ofOzz and that interaction between the two
native proteins occurs in the differentiated muscle fibers.
Ozz Mediates Ubiquitination of Alix—Alix and Ozz interac-
tion implied that Alix can be a substrate of theOzz-E3 ligase. In
this regard, it is noteworthy that the minimal region of Alix
needed for its interaction with Ozz encompasses and is in close
proximity with seven lysines that are predicted to be sites of
ubiquitination with medium (six) and high confidence (one)
(72% accuracy claimed), by the random forest predictor of ubiq-
uitination sites, UbPred (Fig. 1A) (34). Two of these lysines
(Lys-574 and Lys-699) are completely conserved among evolu-
tionary distant species, which make these residues a likely tar-
get of ubiquitination.
Alix ubiquitination analysis was first performed in C2C12
transfected with an MSCV-based bicistronic retroviral vector
encoding full-length Ozz and the green fluorescent protein
(GFP) (MSCV-Ozz) or a similar vector carrying only GFP
(MSCV-GFP). Subcellular fractions of transfected cells at D3 of
differentiation were immunoprecipitated, in the presence of
calcium,with two commercialmonoclonal anti-Alix antibodies
FIGURE 2. Localization of Alix and Ozz in primarymyotubes. A, represent-
ative confocal microscopy images showing Alix andOzz localization in prolif-
erating (D0) and differentiated (D3) primarymyoblasts. Inmyotubes, Ozz and
Alix displayed a punctated distribution pattern and were colocalized in dis-
crete puncta (arrowheads) and in the proximity of the nucleus. Scale bar, 10
m. B, computational analyses of several confocal images fromOzzwild-type
or knock-out D3myotubes (n 5–6) confirmed the colocalization of the two
fluorescent signals. The right panel shows the Pearson’s correlations. The
colocalization between Alix (green fluorescence) and Ozz (red fluorescence) is
also shown as scatter plots (cytofluorograms) in the center and left panels.
Ozz/ cells were included in this analysis as negative control. Standard devi-
ations (error bars) andp values (***,p0.005) confirmed that the analysiswas
statistically significant.
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(clones 3A9 and 2H12) or an isotype-matching antibody (anti-
FLAG), and probed on immunoblots with anti-ubiquitin, anti-
Ozz, or anti-Alix antibodies. We found that Alix was ubiquiti-
nated in the cytosolic fraction ofMSCV-GFPmock-transfected
cells (Fig. 3A, 2nd and 4th lanes). However, overexpression of
Ozz induced a significant increase of Alix ubiquitination levels
(Fig. 3A, 3rd and 5th lanes), suggesting that Ozzmediates ubiq-
uitination of endogenous Alix in myotubes. Both the 3A9 and
2H12monoclonal antibodies did not efficiently precipitate Alix
from the membrane fractions, likely because of the detergent
that was used in these preparations (data not shown). However,
we chose to test the 2H12 monoclonal antibody because it was
shown to recognize an epitope within the hydrophobic pocket
of Alix that is exposed only in its “open” conformation (35). The
use of this antibody would allow us to discriminate between
different forms of Alix and to assess whether interaction with
Ozz could modify the conformation of Alix. In the presence of
calcium, the 2H12 clone immunoprecipitated Alix from the
cytosol of mock-transfected cells, although with lower effi-
ciency than clone 3A9 (Fig. 3A, 4th versus 2nd lane). In contrast,
overexpression of Ozz resulted in a significant increase in the
amount of native Alix immunoprecipitated by the 2H12 clone,
suggesting that Ozz promotes the open conformation of Alix
(Fig. 3A, 5th versus 4th lane).
To further ascertain whether Alix was a target of ubiquitina-
tion by the Ozz-E3, we performed an in vitro ubiquitination
assay, using a reconstituted Ozz-E3 complex and a GST-tagged
recombinant Alix (119 kDa) (29, 30). The ubiquitinated prod-
ucts were immunoprecipitated with anti-Alix, and the immu-
noblots were probed with anti-ubiquitin antibody (Fig. 3B).
Recombinant Alix was ubiquitinated only in the presence of the
Ozz-E3 (Fig. 3B, compare 1st and 3rd lanes). Three other GST
fusion proteins, used as internal controls, were not ubiquiti-
nated in this assay (data not shown), which validated the spec-
ificity of the reaction. In an attempt to identify the lysine resi-
due(s) ubiquitinated by the Ozz-E3 complex, we generated two
Alix point mutants (K574R and K699R), targeting the twomost
conserved ubiquitination sites among Alix homologs. These
mutant proteins were tested in the ubiquitination assay. How-
ever, their rate of ubiquitination by the Ozz-E3 complex dif-
fered only marginally to that of wild-type Alix, indicating that
additional lysines might be targets of the ligase (data not
shown).
We next tested if Alix was ubiquitinated in vivo byOzz and if
this modification occurred in a specific subcellular pool of the
protein in the differentiatedmyotubes. The extent of Alix ubiq-
uitination was assessed in subcellular fractions ofOzz/myo-
tubes, and we compared it with that inOzz/ cells (D3). Using
2H12 antibody, we immunoprecipitated a slightly higher
amount of ubiquitinated Alix from the cytosolic fraction of
wild-type myotubes than from the same fraction of Ozz null
myotubes (Fig. 3C). This difference was more evident when the
ubiquitinated Alix was immunoprecipitated with anti-ubiqui-
tin antibody. Furthermore, inOzz null myotubes there was less
Alix immunoprecipitable with the 2H12 clone (Fig. 3C). In line
with the Ozz overexpression experiments, these results imply
that lack of Ozz leads to a decreased amount of Alix in its open
conformation, which can be immunoprecipitated by the 2H12
antibody. Ectopic expression of Ozz, or its loss of function,
could therefore influence the balance between the open versus
the closed Alix conformation. These findings suggest that Ozz
may exert a dual function toward Alix, modulating its confor-
mation and ubiquitination status.
Knockdown of Alix Alters the F-actin Levels and Distribution
in Muscle Cells—To elucidate the biological significance of the
Ozz-Alix interaction in skeletal muscle, we first analyzed the
expression pattern of Alix and the effects of its loss of function
in C2C12 cells. Subcellular fractions prepared from C2C12
myoblast (D0) and myotubes (D3) showed that Alix was
expressed at high levels in both proliferating (D0) and differen-
tiated (D3) cells (Fig. 4A). Alix wasmainly localized in the cyto-
plasmic fraction and in the fraction comprising the sarcolemma
and the intracellular membranes (Fig. 4A). Silencing of Alix in
C2C12 using two independent siRNA pools (see “Experimental
Procedures”) was specific and effective, as we routinely
obtained 70–90% knockdown of Alix expression, compared
with mock-transfected cells (Fig. 4A). The expression patterns
of the early markers of myoblast differentiation (i.e. myogenin
and MyHC) did not change in the Alix-silenced C2C12 com-
pared with mock-treated cells nor did the viability, morphol-
ogy, and migration of cells treated with two different nontar-
geting siRNA pools (data not shown). Immunofluorescence
microscopy showed that mock-transfected C2C12 myoblasts
displayed a fibroblastoidmigratory shape with numerous stress
fibers and protrusions extending from one cell to the adjacent
cell (Fig. 4B, left panel). In contrast, the knockdown of Alix
resulted in a substantial number of cells acquiring a less motile
phenotype and a different morphology, with a clearly reduced
number of protrusions and less organized stress fibers (Fig. 4B,
right panel). TheseAlix-silencedmyoblasts exhibited a redistri-
bution of F-actin at the cell periphery, in areas juxtaposed to the
submembranous cytoplasm.
To quantify the effects of Alix on F-actin assembly, we com-
pared the mean cellular F-actin content of C2C12 myoblast
silenced for Alix with that of mock-transfected cells, using
FITC-phalloidin staining followed by FACS analyses. Themean
value of phalloidin intensity measured in individual cells
treatedwithAlix siRNAwas quantified and comparedwith that
FIGURE 3. Ozz-E3 complex ubiquitinates Alix in vitro and in vivo. A, the ubiquitination of Alix was assessed in the cytosolic fractions of C2C12 transfected
with an empty vector (Mock) or a vector containing Ozz cDNA (Ozz overexpressing), at D3 of differentiation. Proteins were immunoprecipitated (IP) with two
anti-Alix antibodies (clone 3A9 and 2H12) and immunoblotted with the indicated antibodies. The level of Alix in the cytosolic fraction is also reported. Band
intensitieswere acquired using anOdyssey Infrared Imaging System (LI-COR), at lowor high detection sensitivity.WB, Western blot. B, in vitro ubiquitination of
GST-tagged Alix was performed in presence or absence of the reconstituted Ozz-E3 complex and GST-Alix. Ubiquitinated Alix was immunoprecipitated with
anti-Alix and detected on immunoblot probed with anti-ubiquitin. C, Alix level and the extent of Alix ubiquitination was compared in subcellular fractions
(cytosol and membrane/organelle) of Ozz/ (WT) and Ozz/ (KO) primary myotubes. Anti-ubiquitin immunoprecipitated more ubiquitinated Alix in the
cytosolic fraction of the wild-type myotubes at D3 of differentiation than in the Ozz null myotubes. Similarly, the amount of native Alix immunoprecipitated
with the anti-Alix clone 2H12 was significantly more in the cytosolic fraction of the wild-type than in the Ozz null myotubes.
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of themock-treated population. Knockdown of Alix expression
induced a significant decrease in the mean cellular content of
F-actin, a finding that supports a direct role of Alix in regulating
actin dynamics also in muscle cells (Fig. 4C).
Effect of Alix Loss of Function on Three-dimensional Cultures
of Muscle Cells—Gross morphological and intracellular
changes in muscle cells during differentiation can be readily
identified by ultrastructural analysis of three-dimensional cul-
tures, a method that could give insights into skeletal muscle
morphogenesis. One particular morphological change that
occurs during the transition from monolayer culture to the
three-dimensional environment is the appearance of cytoplas-
mic projections (36). Thus, to investigate the role of Alix in
maintaining cell morphology and in the formation of cell pro-
jections, Alix-depleted and mock-treated cells were cultured
three-dimensionally in a collagen I gel matrix under both pro-
liferating and differentiating conditions. Mock-transfected
C2C12 migrated inside the collagen gel matrix within 24–48 h
after plating and created a small round mass. In contrast, Alix-
depleted cells moved in flat motion andmigrated less inside the
gelmatrix (data not shown). Transmission electronmicroscopy
analysis of both siRNA-treated andmock-treated three-dimen-
sional cultures demonstrated that the latter cells extended their
sarcolemma into long filopodium-like projections, whereas
Alix-depleted cells had an altered phenotype with aborted pro-
trusions, in both proliferating and differentiating culture con-
ditions (Fig. 5). These results suggest that Alix plays a role in the
formation of cellular projections in both proliferating and dif-
ferentiating muscle cells, which in turn might affect myoblast
migration.
Cell Migration and Rate of Attachment to Substrate Are
Altered inAlix-silencedC2C12—To test this further, themigra-
tion of C2C12 silenced for Alix was monitored using an in vitro
wound healing assay. A cell monolayer was scraped longitudi-
nally, and the rate of migration of the cells into the scraped
surface (wound healing) was evaluated. After 24 h, only 20% of
the Alix-silenced C2C12 migrated into the “wound,” whereas
mock-transfected cells had virtually closed the gap, with a
migratory activity of about 90% (Fig. 6A). Because cell migra-
tion also requires the formation of new focal adhesions to the
substrates, we tested whether Alix is also required during the
adhesion step. For this purpose, the rate of attachment to plas-
tic of siRNA- versusmock-treated C2C12 cells was tested using
an in vitro cell attachment assay (Fig. 6B). At 6min after plating,
only 50% of Alix-depleted cells adhered to the plastic surface
compared with control cells (p  0.05). Attachment of Alix-
silenced cells was statistically less also at 20 min (p  0.05)
compared with control cells, when the cell-substrate contact
stage is concluded and the attachment step is in the logarithmic
phase (37). Their reduced ability to adhere was still detected at
FIGURE 4. Effect of Alix loss of function on F-actin organization in proliferating and differentiated C2C12. A, treatment of C2C12 myoblasts with
Alix-specific double-stranded siRNA pools led to a significant reduction (75%) in Alix expression compared with mock-transfected cells, in different subcel-
lular fractionsof bothproliferating (D0) anddifferentiatedC2C12 (D3). Cellular compartments are as follows: cytosol (cyt);membrane/organelle (3); nuclei (nuc);
cytoskeleton (csk). B, C2C12 cells treatedwith the Alix siRNA pools exhibited an overall reduction of F-actin, in addition to an aberrant localization of F-actin at
the cell periphery, most prominent in the submembranous cytoplasmic areas (FITC-phalloidin stained cells). C, to quantify the effects of Alix-depletion on
F-actin, FITC-phalloidin stained cells were analyzed by FACS.
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60 min when 100% of mock-transfected cells were attached.
Thus, in muscle cells one of the functions of Alix could be to
regulate cell migration by promoting the formation of protru-
sions and adhesions to substrate.
Ozz Depletion Affects the Amount and the Subcellular Distri-
bution of Alix in Differentiated Muscle Cells—Because Alix
silencing affected the levels and distribution of F-actin in
C2C12, we asked whether a similar phenotype could be repro-
duced by the lack of Ozz in differentiated primary myotubes.
Indeed, this was confirmed in Ozz null D3 myotubes that
showed a decreased amount of phalloidin staining compared
with thewild-typemyotubes (Fig. 7A).We then determined the
effect of the loss of function of Ozz on the expression of Alix
and its subcellular distribution in Ozz/ and Ozz/ myo-
tubes. We focused on the pattern of Alix expression in the
actin-containing structures. Various actin-associated proteins
specify different actin-based compartments and determine
their properties and regulation. Given that Alix interacts with
cortactin, an actin-binding protein that couples membrane
dynamics to the cortical actin cytoskeleton (38–40), we
checked the distribution of Alix and cortactin both in wild-type
andOzz null muscle cells. Z-stack analyses of confocal micros-
copy images showed that Alix and cortactin colocalized in dis-
crete regions of D3 wild-type primary myotubes (Fig. 7B,
merged images of WT myotubes). In contrast, Ozz/ myo-
tubes showed increased amount of Alix throughout their cyto-
FIGURE 5. Alix depletion affects the formation of filopodia-like structures in three-dimensional culture of C2C12 muscle cells. Transmission electron
microscopy of three-dimensional cultures of C2C12 proliferating (D0) and differentiating (D3) cells silenced for Alix showed an altered phenotype, compared
with mock-treated cells.
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sol, with a fraction of the protein accumulating in cortactin
positive puncta (Fig. 7B, merged images of KOmyotubes). This
immunofluorescence staining of Alix was paralleled by an
increased amount of the protein in both the cytosolic andmem-
brane/organelle subcellular fractions of Ozz/ myotubes, as
demonstrated by immunoblot analysis of Alix in these fractions
(Fig. 7C). These results were confirmed by quantitative analysis
of post-nuclear lysates of Ozz/ and Ozz/ myotubes from
three independent measurements (Fig. 7D). Together, these
data put forward a role of Ozz in modulating the proper local
concentration and distribution of Alix.
DISCUSSION
Fine-tuning the levels of specific subcellular pools of both
structural and regulatory proteins in muscle cells is fundamen-
tal to their growth, differentiation, and regeneration. During
these processes, ubiquitin modification or ubiquitin-mediated
degradation of target substrates plays a central role. We have
previously identified a RING-type ubiquitin ligase complex,
Ozz-E3, whose substrate recognition component, Ozz, is
expressed exclusively in striated muscle and is up-regulated
duringmuscle growth and regeneration (29, 30).We found that
Ozz-E3 participates in the processes ofmyofiber differentiation
and sarcomere stability by controlling the levels of cadherin-
associated -catenin (29), and sarcomeric MyHCemb (30).
Thus, Ozz-E3 recognizes and ubiquitinates only selected pools
of these two substrates, both of which directly or indirectly
interact with polymerized actin, either in the sub-cortical
region (-catenin) or in the sarcomere (MyHCemb). We now
have identified a new substrate of Ozz in muscle cells, Alix,
whose function in muscle has not been investigated before.We
found that Alix is expressed throughout themyogenic differen-
tiation and that a specific pool of Alix colocalizes in discrete
subcellular regions positive for Ozz.
Alix is an evolutionary conserved, ubiquitously expressed
adaptor protein that has been implicated in many cellular pro-
cesses, including membrane and cytoskeleton remodeling (12).
In fact, Alix has been shown to associate with F-actin in epithe-
lial cells and fibroblasts, where it participates in the organiza-
tion of actin fibers (14). In addition, Alix can bind to acidic
phospholipids via its Bro1 domain, which structurally resem-
bles a “boomerang” with the convex face containing a positively
charged region (41). This convex surface might function as
membrane bending domain to generate or scaffold a negative
curvature within the membrane (42). A potential interplay
between F-actin andmembrane bending domains is thought to
occur during the processes of filopodia formation (negative
membrane curvature) and endocytosis (positive membrane
curvature) (42). By silencing the expression of Alix in C2C12
cells, we were able to demonstrate that loss of Alix does not
interfere with the early myogenic program but rather with
structural events, such as F-actin levels and distribution, and
proper formation of membrane protrusions. The latter process
was particularly evident in three-dimensional cultures, which
showed aberrant formation of podia upon loss of Alix both in
myoblast and myotubes. Thus, Alix could control both cyto-
skeleton andmembrane dynamics inmuscle cells by interacting
with the F-actin cytoskeleton and at the same time by acting as
a membrane bending component. Proper podia formation is
also important for cellmigration, a fundamental process during
skeletal muscle fiber differentiation and regeneration. Because
Alix silencing also perturbs muscle cell migration, it is possible
that normally Alix takes part in this process by regulating the
formation of filopodia and the actin cytoskeletal dynamics.
The function of ubiquitin tagging and degradation, as it per-
tains to the regulation of assembled and little accessible struc-
tural components (e.g.membrane and/or cytoskeletal proteins)
inmuscle, is still poorly understood.This is further complicated
by the existence of multiple pools of protein substrates that
interact with a plethora of partners at different subcellular sites.
In this respect, Ozz and the ligase complex it specifies represent
themeans for the controlled regulation of these substrate pools,
of which Alix is one constituent.
It has been recently reported that in overexpressing human
cell lines, Alix interacts with and is ubiquitinated by the one-
chain ligases POSH and Nedd4-1 during the process of virus
budding (25, 26). It is noteworthy that the interaction of Alix
with these two ligases was detected only in the presence of
detergents. In contrast, Ozz is able to recognize Alix in its
closed conformation without the aid of detergents, probably
functioning as a crowbar to convert it into its open conforma-
tion.Ozz uses an analogousmode of action toward its other two
substrates (-catenin and MyHCemb) that are bound by Ozz in
their assembled state (29, 30). In the case of MyHCemb, Ozz
targets the rod portion of this protein, which forms the core of
FIGURE 6.Alix negativelymodulatesmuscle cell migration and adhesion
to substrate. A,wound healing assays showed that Alix-silenced C2C12 cells
have an altered pattern of cell migration, compared with mock-treated cells.
B, silencingofAlix expression reduced the capacity ofC2C12cells to adhere to
plastic. The percentage of C2C12 cells adhering to plastic was evaluated at
each time point. Values are expressed as mean of three independent experi-
ments, and error bars indicate standard deviations. Mean differences were
considered statistically significant when p values were0.05 (*).
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sarcomeric thick filaments and is not easily accessed by other
proteins. Similarly, Ozz recognizes a difficult to access pool of
-catenin located at the sarcolemma, where this protein is
assembled in a multiprotein complex, including cadherin and
cortical actin.
We have postulated that Ozz binding to MyHCemb does not
immediately initiate the ubiquitination and proteolytic degra-
dation of this substrate, but rather renders it accessible for fur-
ther ubiquitination by the Ozz-E3. Based on our current data,
we now propose that Ozz may exert a similar function on Alix
FIGURE 7. Subcellular distribution of actin, Alix, and cortactin in wild-type and Ozz null primary myoblasts. A, Ozz null myotubes exhibited an overall
reduction of F-actin. B, representative confocalmicroscopy images showing that Alix and cortactin colocalized in discrete regions inWTmyotubes. Loss of Ozz
resulted in accumulation of Alix in large puncta positive for cortactin (see inset). Scale bar, 10 m. C, Alix expression levels were compared on immunoblots
containing the cytosolic and membrane/organelle fractions from the Ozz null and wild-type D3 myotubes. D, quantitative analysis of post-nuclear fractions
fromwild-type andOzz-null myotubes. Alix expressionwas significantly higher in differentiatedOzz/myotubes comparedwithOzz/myotubes. Data are
expressed as mean S.D. of three independent experiments. Mean differences were considered statistically significant when p values were less than 0.05 (*).
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by binding to a hydrophobic, low accessible pocket of the pro-
tein, thereby changing its conformation and making it accessi-
ble for further ubiquitination. In addition, the Ozz-mediated
conformational change of Alix appears to affect also the subcel-
lular localization of the protein. In fact, we found thatAlix accu-
mulates in a cortactin-positive subcompartment in the absence
of Ozz. Our findings are in agreement with the concept sug-
gested by Sundquist and co-workers (22) that opening of the
“hinge region” of Alix is driven by post-translational modifica-
tions and/or ligand binding. Opening of the V domain would
expose different binding sites and consequently modify the
function and subcellular localization of Alix (22). This pro-
posed model was recently corroborated by the same authors,
who demonstrated that Alix activation/localization requires
dissociation of the auto-inhibitory PRR and opening of the V
domain arms (43). Therefore, it appears that all the substrates
of Ozz identified to date, including Alix, are targeted by this
protein in their assembled state and again might require Ozz
binding to change conformation and/or to dissociate from their
protein partners before their ubiquitination. In this capacity,
Ozz may represent a novel regulator of Alix in muscle cells.
We have proposed earlier that the defects in myofibrillogen-
esis and sarcomere stability observed in theOzzKOmuscle are
due to relatively small changes in the concentration of mem-
brane--catenin and MyHCemb (29, 30). Considering the
involvement of Alix in modulating actin dynamics in muscle
cells, we have focused on the effects of Ozz depletion in the
organization of the cortical actin cytoskeleton. We found that
the abnormal F-actin levels and organization observed in Alix-
silenced C2C12 were recapitulated in the primary myotubes
lacking Ozz expression. Given the similarity in the way Ozz
recognizes and regulates its substrates at specific subcellular
sites, we can infer that variations in the local concentration of
Alix may also contribute to the overall muscle defects charac-
teristic of the Ozz KOmice.
In conclusion, Alix plays a primary role in modulating actin
dynamics in muscle cells, and the role of Ozz in this process is
required mainly in the differentiating myotubes when the con-
trol of the concentration of Alix at specific sites of the elongat-
ing myofiber might be crucial.
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